metaraminol has been researched along with Cancer of Intestines in 2 studies
Metaraminol: A sympathomimetic agent that acts predominantly at alpha-1 adrenergic receptors. It has been used primarily as a vasoconstrictor in the treatment of HYPOTENSION.
metaraminol : A member of the class of phenylethanolamines that is 2-amino-1-phenylethanol substituted by a methyl group at position 2 and a phenolic hydroxy group at position 1. A sympathomimetic agent , it is used in the treatment of hypotension.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| LEVINE, RJ | 1 |
| SJOERDSMA, A | 1 |
| ANNINO, G | 1 |
| BRANZI, GC | 1 |
2 other studies available for metaraminol and Cancer of Intestines
| Article | Year |
|---|---|
Pressor amines and the carcinoid flush.
Topics: Amines; Carcinoid Tumor; Epinephrine; Intestinal Neoplasms; Isoproterenol; Liver Neoplasms; Mephente | 1963 |
[CLINICAL EXPERIENCE IN TREATMENT OF SOME CASES OF HYPOTENSION AND SHOCK WITH METARAMINOL (LEVICOR)].
Topics: Cachexia; Humans; Hypotension; Intestinal Neoplasms; Metaraminol; Myocardial Infarction; Pericarditi | 1964 |